Skip to main content
Screener/Healthcare/Drug Manufacturers - Specialty & Generic

LNTH — Lantheus Holdings, Inc.

NASDAQ
$100.33+0.01 (+0.01%)
Mid CapHealthcareHigh ROE
$50.16
$111.86
$100.24
$100.50
EPS (TTM)$3.37
P/E Ratio29.77
Dividend Yield—
Market Cap$6.52B
Volume233K
Prev Close$100.32
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$406.8M$54.1M$0.8259.2%13.3%
Q3 '25$384.0M$27.8M$0.4157.9%7.2%
Q2 '25$378.0M$78.8M$1.1263.8%20.8%
Q1 '25$372.8M$72.9M$1.0263.8%19.6%
Q4 '24$391.1M-$11.8M$-0.1763.5%-3.0%
Q3 '24$378.7M$131.1M$1.7963.9%34.6%
Q2 '24$394.1M$62.1M$0.8864.9%15.8%
Q1 '24$370.0M$131.1M$1.8768.1%35.4%
Get Your Daily Market Recap